Evidence map›Paper›PMID 27264503›Full record

ArticleSchizophrenia research2016

Corrigendum to "abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21].

Patricia Alvarado-Alanis, Pablo León-Ortiz, Francisco Reyes-Madrigal, Rafael Favila, Oscar Rodríguez-Mayoral, Humberto Nicolini, Mariana Azcárraga, Ariel Graff-Guerrero, Laura M Rowland, Camilo de la Fuente-Sandoval

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Schizophrenia research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Patricia Alvarado-AlanisLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Pablo León-OrtizLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; Department of Education, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Francisco Reyes-MadrigalLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Rafael FavilaMR Advanced Applications, GE Healthcare, Mexico City, Mexico.
Oscar Rodríguez-MayoralEarly Psychosis Intervention Department, Hospital Fray Bernardino Álvarez, Mexico City, Mexico; Palliative Care Unit, Instituto Nacional de Cancerología, Mexico City, Mexico.
Humberto NicoliniInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Mariana AzcárragaNeuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Ariel Graff-GuerreroMultimodal Neuroimaging Schizophrenia Group, Research Imaging Centre and Geriatric Mental Health Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Canada.
Laura M RowlandMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, USA; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, USA.
Camilo de la Fuente-SandovalLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; Neuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. Electronic address: fcamilo@unam.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27264503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.